|Articles|March 1, 2013
- Pharmaceutical Executive-03-01-2013
- Volume 0
- Issue 0
PE, March 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 12 years ago
Less Selling, More Timeover 12 years ago
Test and Learn: Making Confident Decisions on the Commercial Sideover 12 years ago
China and the Emerging Markets Challengeover 12 years ago
Embedding Market Access in Today's Pharma Business Modelover 12 years ago
Who's Really in Charge of European Drug Registration?over 12 years ago
Brand of the Year: Januviaover 12 years ago
Early Engagement with Medical Laboratoriesover 12 years ago
Pharma in the News: Pharm Exec's Annual Press Auditover 12 years ago
Safeguarding the Value of Patent AssetsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
2
The Importance of Suppressor Cells in Tumor Progression
3
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
4
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
5
